April 24, 2021
Acute Care, Neurologic
This course will be a thorough review of basic immune system physiology, principles of immunotherapy in general, and a specific overview of the novel oncologic treatment of CAR T-Cell therapy. This treatment will be reviewed in detail in terms of its mechanism, targeted cancers, and side effects. Common side effects, such as Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS), will be more thoroughly explained in this lecture. As this is a newer treatment, there is limited evidence on implications for physical therapists working with patients who may experience side effects of this treatment; this lecture aims to cover this topic based on currently available evidence.Expand summary
Program Titles and Supporting Materials
This program contains the following components:
If applicable, you may obtain credit in multiple jurisdictions simultaneously for this program (see pending/approved list below). If electing credit for this program, registrants in jurisdictions not listed below will receive a Certificate of Completion that may or may not meet credit requirements in other jurisdictions. Where applicable, credit will be only awarded to a paid registrant completing all the requirements of the program as determined by the selected accreditation authority.
How to Attend
Join the self-paced program from your office, home, or hotel room using a computer and high speed internet connection. You may start and stop the program at your convenience, continue where you left off, and review supporting materials as often as you like. Please note: Internet Explorer is no longer a supported browser. We recommend using Google Chrome, Mozilla Firefox or Safari for best results.
You may access this course on a computer or mobile device with high speed internet (iPhones require iOS 10 or higher). Recommended browsers are Google Chrome or Mozilla Firefox.